| Literature DB >> 35836928 |
Julien Soichot1, Nathalie Guttmann1, Hubert Rehrauer2, Nicole Joller3, Lucienne Tritten1.
Abstract
Parasitic nematodes are masterful immunomodulators. This class of pathogens has evolved a spectrum of sophisticated strategies to regulate and evade host immune responses, mediated through the release of various molecules. In this context, the release of microRNAs (miRNAs), short post-transcriptional regulators of gene expression, has been of particular interest in the host-parasite interplay. Evidence that parasite-derived miRNAs modulate host innate and adaptive immune responses has become increasingly compelling. However, since miRNAs are usually contained in extracellular vesicles containing other mediators, it is difficult to assign an observed effect on host cells to miRNAs specifically. Here, the effects of some abundantly secreted miRNAs by nematodes used as models of gastrointestinal infections (Heligmosomoides polygyrus bakeri, Trichuris muris and Ascaris suum) were evaluated, addressing the potential of parasite miRNAs to impair in vitro differentiation of two important types of immune cells in the context of helminth infections, Th2 lymphocytes and macrophages. Mimicking a continuous exposure to low concentrations of nematode miRNAs, the interferon gamma signaling, the IL-2/STAT5 signaling, and the mTOR signaling pathways were identified as downregulated by Hpo-miR-71-5p. Interferon regulatory factor 4 (Irf4) was validated as a target of Hpo-miR-71-5p, while Mtor is targeted by Asu-miR-791-3p, abundant in the T. muris secretions. By trend, Hpo-miR-71-5p impacts mildly but consistently on the amounts of inflammatory cytokines in unpolarized macrophages but leads to slightly increased IL-10 level in alternatively activated cells. In addition, our data suggests that transfected miRNAs remain for days in recipient cells, and that Hpo-miR-71-5p can incorporate into mouse Argonaute protein complexes. Nematode miRNAs can impair both innate and adaptive arms of host immunity. Hpo-miR-71-5p in particular, absent in mammals, interacts with host genes and pathways with crucial involvement in anthelmintic immune responses. This report brings new insights into the dynamics of miRNA-driven immunomodulation and highlights putative targeted pathways. Although the absolute repression is subtle, it is expected that the dozens of different miRNAs released by nematodes may have a synergistic effect on surrounding host cells.Entities:
Keywords: IRF4; T cells; cytokines; immunomodulation; mTOR; macrophages; microRNA; parasitic nematode
Year: 2022 PMID: 35836928 PMCID: PMC9274173 DOI: 10.3389/fmolb.2022.909312
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
FIGURE 1Schematic transcriptional network and positive regulation during Th2 lymphocyte differentiation and interference by nematode miRNAs. Elements in red represent genes of which at least some isoforms represent predicted targets of the 20 most abundantly secreted H. polygyrus bakeri, T. muris and A. suum miRNAs. Briefly, T cell receptor (TCR) stimulation activates downstream molecules such as nuclear factor of activated T-cells (NFAT), nuclear factor-κB (NFκB), and AP-1, in turn leading to upregulation of interferon regulatory factor 4 (IRF4) (Zhu, 2015). IL-4-mediated Stat6 activation and other signaling pathways also induce GATA3 expression. GATA3 may directly or indirectly regulate Th2 cytokine expression by inducing other transcription factors such as c-Maf, JunB, or Dec2, some of which may further sustain GATA3 expression. The IL-2—Stat5 axis is also crucial for Th2 cytokine production and was significantly downregulated by our transfected miRNAs (orange block). Activated T cells produce IL-2 and IL-4, among others, upregulating IL-2 and IL-4 receptors, creating a positive feedback loop. mTOR in the complex mTORC2 is required for Th2 differentiation via two mechanisms: i) repression of expression of negative regulators of IL4-R and STAT6, and ii) promotion of NF-κB-mediated transcription (Chi, 2012). Some elements of this image were created with Biorender.com
FIGURE 2Cell counts and proportions of fully differentiated Th2 cells. Cell counts after 92 h into culture (A) and proportion of Th2 cells at the end of the experiments (96 h, (B), as reflection of IL-13 positive labeling, measured by FACS. Colors indicate independent experiments; stars indicate the mean for each miRNA treatment. Cell counts are expressed in log10 of average cell counts.
FIGURE 3Transfection efficiency. (A–C) Raw 264.7 macrophages (mϕ) transfected with a fluorescent oligonucleotide (representative examples). (A) 83.8% of unpolarized macrophages showed FITC fluorescence 1 h post transfection with BLOCK-iT fluorescent oligonucleotide (FITC labeled) and lipofectamine (red). Cells exposed to the oligo only are shown in blue, or to the transfection reagent only, in orange. (B) Classically activated macrophages (M1) showed only 31.7% transfection efficiency with the fluorescent oligo and lipofectamine (red). (C) Alternatively activated macrophages (M2) showed a high transfection efficiency, similar to M0 cells, with 82.7% cells showing FITC labeling. Transfection efficiency in differentiating Th2 cells (D–F). CD4+ naïve T cells were transfected with BLOCK-iT fluorescent oligo upon start of the differentiation protocol (day 0). Transfection efficiency was measured after 1 h (D) and again after 48 h (E). Cells transfected at the end of the differentiation protocol (96 h) showed 87.8% of FITC-labelled cells when the oligo was introduced into cells with lipofectamine (F). (G) Live cell imaging of transfected differentiating Th2 cells. CD4+ T cells were transfected at 96 h of Th2 differentiation with a FITC-labelled oligo (green) and imaged 1 h post-transfection (magnification: 60 x). Lysosomes were stained with Lyso-Tracker red DND-99 (red). There is a priori no co-localization between introduced oligonucleotides and lysosomes. (H) Real-time PCR amplification of Hpo-miR-71-5p from miRNA following mouse AGO pull-downs, 4 h after transfection of Th2 cells with miRNA mimics. miRNA transfected samples are represented by blue, red, and green replicate curves.
Most strongly up- and downregulated pathways. DE genes (p < 0.01) were submitted to Enrichr for pathway enrichment against the MSigDB Hallmark 2020 library. Combo: combination of miR-100, miR-10021, and miR-71 in equal parts, where the total amount of miRNA introduced is the same as for individual miRNAs (i.e., 10 nM). UNC: universal negative control. Data for miR-100, miR1 and combo are from two independent experiments only.
| Downregulated Pathways by miRNA transfection Compared with the UNC miRNA | |||
|---|---|---|---|
| Pathway Name | Adj. | Contributing genes | |
| miR-100* vs UNC | - | - | - |
| miR-71 vs UNC | Interferon Gamma Response | <0.01 |
|
| IL-2/STAT5 Signaling | 0.04 |
| |
| mTORC1 Signaling | 0.04 |
| |
| miR-10021 vs UNC | - | - | - |
| Combo* vs UNC | Interferon Alpha Response | 0.07 |
|
| miR-1* vs UNC | Protein Secretion | 0.06 |
|
| Oxidative Phosphorylation | 0.06 |
| |
| mTORC1 Signaling | 0.06 |
| |
| Myc Targets V1 | 0.06 |
| |
| Transfection reagent vs UNC | IL-2/STAT5 Signaling | <0.01 |
|
| mTORC1 Signaling | 0.01 |
| |
| Inflammatory Response | 0.01 |
| |
| Fatty Acid Metabolism | 0.04 |
| |
|
| |||
| - |
|
|
|
| Transfection reagent vs UNC | TNF-alpha signaling | <0.01 |
|
| Apoptosis | 0.01 |
| |
| Interferon Gamma Response | 0.01 |
| |
| Complement | 0.01 |
| |
| UV Response Up | 0.03 |
| |
| IL-2/STAT5 Signaling | 0.04 |
| |
| Inflammatory Response | 0.04 |
| |
| heme Metabolism | 0.04 |
| |
FIGURE 4Validation of direct interactions between miRNAs and predicted targets. Relative luciferase activity is significantly decreased due to the insertion of a miR-71 binding site on Irf4 (A). Signal repression was stronger at 50 nM miRNA (p < 0.001, t-test) than at 25 nM (p = 0.02). Similarly, 50 nM or 25 nM miR-791 led to a decrease in luminescence signal (p = 0.02 and p = 0.03, respectively; (D), confirming an interaction between miR-791 and its predicted binding site in Mtor. No significant decrease in luminescence was detected in all other miRNA:binding site combinations (Gata3:miR-10021 (B), and Il4ra:miR-87a (C)). *p < 0.05, ***p < 0.01.
FIGURE 5Cytokine/chemokine concentrations in supernatants of macrophages exposed to nematode miRNAs. For each analyte, colors indicate replicates, stars indicate the mean across three data points. (A,B) Chemokine/cytokine concentration (in pg/ml) varying upon miRNA transfection of M0 macrophages. (C) Chemokine/cytokine concentration (in pg/ml) varying upon miRNA transfection and polarization toward the alternative activation profile M2. IP-10: IFN-γ-induced protein 10 (Cxcl10); MCP-1: monocyte chemoattractant protein 1 (CCl2); MIP-1a: macrophage inhibitory protein 1a; MIP-2: macrophage inhibitory protein 2; RANTES: regulated upon activation, normal T cell expressed and presumably secreted (CCl5); IL-10: interleukin 10; KC: keratinocytes-derived chemokine (CxCl1); M-CSF: macrophage colony-stimulating factor (Csf1); TNF-α: tumor necrosis factor 1α. All concentrations were within range of detection 3.2–10,000 pg/ml (and 12.8–40,000 pg/ml for IL-13). Statistical significance of variation across conditions was performed against Neg. ctrl (UNC) using the Dunnett’s test.